NASDAQ: INGN - Inogen, Inc.

Yield per half year: +23.68%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis Inogen, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (90.67%) is higher than the sector average (-12.5%).

Disadvantages

  • Price (10.03 $) is higher than fair price (8.95 $)
  • Dividends (0%) are below the sector average (0.541%).
  • Current debt level 6.72% has increased over 5 years from 1.5%.
  • The company's current efficiency (ROE=-50.02%) is lower than the sector average (ROE=9.61%)

Similar companies

Illumina

Amarin

ImmunoGen

DENTSPLY SIRONA

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Inogen, Inc. Healthcare Index
7 days 9.3% 2.5% 0.7%
90 days 23.2% -17.8% 2.2%
1 year 90.7% -12.5% 26%

INGN vs Sector: Inogen, Inc. has outperformed the "Healthcare" sector by 103.17% over the past year.

INGN vs Market: Inogen, Inc. has outperformed the market by 64.68% over the past year.

Stable price: INGN is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: INGN with weekly volatility of 1.74% over the past year.

3. Summary of the report

3.1. General

P/E: 98.76
P/S: 0.4244

3.2. Revenue

EPS -4.42
ROE -50.02%
ROA -31.41%
ROIC -5.24%
Ebitda margin -14.65%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (10.03 $) is higher than the fair price (8.95 $).

Price is higher than fair: The current price (10.03 $) is 10.8% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (98.76) is higher than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (98.76) is higher than that of the market as a whole (49.04).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (0.6541) is lower than that of the sector as a whole (4.83).

P/BV vs Market: The company's P/BV (0.6541) is lower than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.4244) is lower than that of the sector as a whole (33.77).

P/S vs Market: The company's P/S indicator (0.4244) is lower than that of the market as a whole (10.24).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-0.6573) is higher than that of the sector as a whole (-22.17).

EV/Ebitda vs Market: The company's EV/Ebitda (-0.6573) is lower than that of the market as a whole (28.32).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 321.5% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (321.5%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).

5.4. ROE

ROE vs Sector: The company's ROE (-50.02%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (-50.02%) is lower than that of the market as a whole (10.71%).

5.5. ROA

ROA vs Sector: The company's ROA (-31.41%) is lower than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (-31.41%) is lower than that of the market as a whole (6.47%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-5.24%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-5.24%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (6.72%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 1.5% to 6.72%.

Excess of debt: The debt is not covered by net income, percentage -21.4%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
01.12.2023 Glezer Stanislav
EVP, Chief Technology Officer
Purchase 5.65 25 736 4 555
01.12.2023 Somer Jason
EVP, Gen. Counsel & Secretary
Purchase 5.65 3 254 576

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Inogen, Inc.

9.3. Comments